From: Airway disease decreases the therapeutic potential of epithelial stem cells
 | Pediatric Patients (N = 48) |
---|---|
Age (years, [SD]) | 3.5 years [3.6] |
Sex | Â |
 Male | 32 (67%) |
 Female | 16 (33%) |
Race | Â |
 White/Caucasian | 37 (77%) |
 Black/African American | 8 (17%) |
 Multi-racial/Other | 3 (6%) |
 BMI percentile (mean [SD]) | 51.6 [35] |
Prematurity (gestational age at birth) | Â |
 At term | 18 (38%) |
 32–37 weeks (moderate/late preterm) | 18 (38%) |
 29–32 weeks (very preterm) | 4 (8%) |
 < 28 weeks (extremely preterm) | 8 (16%) |
Primary clinical indications for DLB | Â |
 Recurrent croup | 8 (17%) |
 Stridor | 8 (17%) |
 Part of other procedure | 6 (13%) |
 Surveillance following airway surgery | 5 (10%) |
 Aspiration | 5 (10%) |
 Tracheal obstruction/lesion | 4 (8%) |
 Supraglottic obstruction/lesion | 4 (8%) |
 Dysphonia | 4 (8%) |
 Subglottic obstruction/lesion | 3 (6%) |
 Failure to extubate | 1 (2%) |